P61L (p.Pro61Leu) variant of PKD1 (Polycystin-1)

P61L (p.Pro61Leu) in PKD1 (Polycystin-1) is a missense change. Clinical records from EBI and UniProt describe it as benign in the context of in PKD1. The available variant effect predictions contribute to a CATVariant prioritization score of 0.32 / 1. The record also includes population frequency data, published literature, and structural context.

P61L (p.Pro61Leu) variant details